The present disclosure relates to crystalline solid forms of a stimulator of soluble guanylate cyclase (sGC), Compound I. Also provided herein are methods for the preparation of these solid forms. The invention also relates to pharmaceutical formulations and dosage forms comprising these solid forms and their uses thereof, alone or in combination with one or more additional agents, for treating and/or preventing various diseases or disorders； these diseases or disorders are ones that may benefit from sGC stimulation or from an increase in the concentration of nitric oxide (NO) and/or cyclic guanosine monophosphate (cGMP).本發明係關於可溶性鳥苷酸環化酶(soluble guanylate cyclase；sGC)刺激劑(化合物I)之結晶固體形式。本發明亦提供用於製備此等固體形式之方法。本發明亦係關於包含此等固體形式之醫藥調配物及劑型以及其單獨或結合一或多種其他藥劑用於治療及/或預防多種疾病或病症的用途；此等疾病或病症為受益於sGC刺激或氧化氮(NO)及/或環單磷酸鳥苷(cGMP)之濃度增加的疾病或病症。
